Examining how menstruation affects blood sugar control and exercise in women with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the influence of hormonal changes during the menstrual cycle on glycemic control in women with type 1 diabetes. It aims to identify personalized patterns of glycemic variability and test adjustments to insulin dosing and food intake based on menstrual cycle phases. Participants will use continuous glucose monitoring (CGM) to track glucose levels over three months and will undergo a randomized intervention to assess the effectiveness of personalized treatment modifications. The study also evaluates how these hormonal factors affect responses to different types of physical activity.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women 18-45 who have had type 1 diabetes for at least 12 months
* Premenopausal with either menstrual cycles or currently using oral contraceptives

Exclusion Criteria:

* Women who are postmenopausal, pregnant, trying to become pregnant, or have had a hysterectomy

Where it's running

• University of Colorado
  Aurora, Colorado, United States Recruiting

Study contacts

• Principal investigator: JANET K SNELL-BERGEON, PhD, MPH — University of Colorado, Denver
• Study coordinator: JANET K SNELL-BERGEON, PhD, MPH
• Email: Janet.Snell-Bergeon@cuanschutz.edu
• Phone: 3037246762

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating the safety and effectiveness of porcine pancreatic cells in patients with Type 1 diabetes

  This study is testing if using pig pancreas cells can help adults with tough-to-manage Type 1 diabetes feel better and avoid dangerous low blood sugar episodes.

  Recruiting Phase 1/2 Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois · NCT06575426

• C-peptide's effect on blood sugar regulation during hypoglycemia

  This study tests if adding C-peptide to insulin can help people with type 1 diabetes and healthy individuals better manage their blood sugar during low blood sugar episodes.

  Recruiting Early Phase 1 University of Cincinnati · Cincinnati, Ohio · NCT06470295

• Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity

  This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.

  Recruiting Phase 2/3 McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07891156

• Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes

  This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.

  Recruiting at 11 sites Medtronic MiniMed, Inc. · Chula Vista, California and 17 other locations · NCT07864168

• Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery

  This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.

  Recruiting at 2 sites Phase 4 Joslin Diabetes Center · Birmingham, Alabama and 1 other locations · NCT07818707

• CGM-guided carb awareness education for adults with Type 1 diabetes

  This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.

  Recruiting University of California, Los Angeles · Los Angeles, California · NCT07807280

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.